References
- Navot D, Bergh PA, Williams M, et al. An insight into early reproductive processes through the in vivo model of ovum donation. J Clin Endocrinol Metab. 1991;72:408–414.
- Simon A, Laufer N. Assessment and treatment of repeated implantation failure (RIF). J Assist Reprod Genet. 2012;29:1227–1239.
- Chaouat G, Dubanchet S, Ledee N. Cytokines: important for implantation? J Assist Reprod Genet. 2007;24:491–505.
- Sharkey A. Cytokines and implantation. Rev Reprod. 1998;3:52–61.
- Sher G, Herbert C, Maassarani G, et al. Assessment of the late proliferative phase endometrium by ultrasonography in patients undergoing in-vitro fertilization and embryo transfer (IVF/ET). Hum Reprod. 1991;6:232–237.
- de Mouzon J, Lancaster P, Nygren KG, et al. World collaborative report on assisted reproductive technology, 2002. Hum Reprod. 2009;24:2310–2320.
- Ndukwe G. Recurrent embryo implantation failure after in vitro fertilisation: improved outcome following intralipid infusion in women with elevated T Helper 1 response. Hum Fertil. 2011;14:21–22.
- Roussev RG, Acacio B, Ng SC, et al. ORIGINAL ARTICLE: duration of intralipid’s suppressive effect on NK cell’s functional activity. Am J Reprod Immunol. 2008;60:258–263.
- Lainas TG, Sfontouris IA, Zorzovilis IZ, et al. Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT). Hum Reprod. 2010;25:683–689.
- Kalfarentzos F, Kokkinis K, Leukaditi K, et al. Comparison between two fat emulsions: intralipid 30 cent vs intralipid 10 cent in critically ill patients. Clin Nutr. 1998;17:31–34.
- Clark DA. Intralipid as treatment for recurrent unexplained abortion? Am J Reprod Immunol. 1994;32:290–293.
- El-Khayat W, El Sadek M. Intralipid for repeated implantation failure (RIF): a randomized controlled trial. Fertil Steril. 2015;104:e26.
- Al-Zebeidi J, Sahar Lary S, Al-Jaroudi D. The effect of fat emulsion intralipid 20% in reproductive outcome for patients with multiple implantation failure. Int J Women’s Health Reprod Sci. 2017;6:144–149.
- Abdolmohammadi-Vahid S, Danaii S, Hamdi K, et al. Novel immunotherapeutic approaches for treatment of infertility. Biomed Pharmacother. 2016;84:1449–1459.
- Check JH, Check DL. Intravenous intralipid therapy is not beneficial in having a live delivery in women aged 40–42 years with a previous history of miscarriage or failure to conceive despite embryo transfer undergoing in vitro fertilization-embryo transfer. Clin Exp Obstet Gynecol. 2016;43:14–15.
- Dakhly DM, Bayoumi YA, Sharkawy M, et al. Intralipid supplementation in women with recurrent spontaneous abortion and elevated levels of natural killer cells. Int J Gynaecol Obstet. 2016;135:324–327.